Is Wave Life Sciences Ltd. (WVE) a Buy, Sell, or Hold?
Wave Life Sciences Ltd.
NASDAQ:WVE
$5.91 USD
-$0.22 (-3.59%)
- Volume
- 1.39M
- Average Volume
- 3.84M
- Market Capitalization
- $1.14B
- P/E Ratio
- -5.58
- Dividend Yield
- 0.00%
- Price Target
- $15.00
- Year High
- $21.73
- Year Low
- $5.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.26
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
58
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
66
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 6.17M
WVE Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
WVE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Wright Christopher I | officer: Chief Medical Officer | 2026-04-09 | 0 | 2026-04-17 | |
| Wright Christopher I | officer: Chief Medical Officer | 2026-04-09 | 5.94 | 2026-04-17 | |
| Wright Christopher I | officer: Chief Medical Officer | 2026-04-09 | 12.75 | 2026-04-17 | |
| Ingelsson Erik | officer: Chief Scientific Officer | 2026-04-09 | 0 | 2026-04-17 | |
| Ingelsson Erik | officer: Chief Scientific Officer | 2026-04-09 | 5.85 | 2026-04-17 | |
| Ingelsson Erik | officer: Chief Scientific Officer | 2026-04-09 | 11.74 | 2026-04-17 | |
| Ingelsson Erik | officer: Chief Scientific Officer | 2026-04-09 | 12.75 | 2026-04-17 | |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-03-30 | P-Purchase | 6.5 | 2026-03-30 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-03-27 | P-Purchase | 6.43 | 2026-03-30 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-03-26 | P-Purchase | 6.38 | 2026-03-30 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2026-03-26 | P-Purchase | 6.06 | 2026-03-30 |
| TAKANASHI KEN | director | 2026-03-23 | C-Conversion | 0 | 2026-03-26 |
| TAKANASHI KEN | director | 2026-03-23 | C-Conversion | 0 | 2026-03-26 |
| Francis Chris | officer: See Remarks | 2026-02-26 | M-Exempt | 3.87 | 2026-02-27 |
| Francis Chris | officer: See Remarks | 2026-02-26 | M-Exempt | 3.87 | 2026-02-27 |
| Francis Chris | officer: See Remarks | 2026-02-26 | M-Exempt | 4.75 | 2026-02-27 |
| Francis Chris | officer: See Remarks | 2026-02-26 | S-Sale | 15.094 | 2026-02-27 |
| Francis Chris | officer: See Remarks | 2026-02-26 | S-Sale | 15 | 2026-02-27 |
| Francis Chris | officer: See Remarks | 2026-02-26 | M-Exempt | 4.75 | 2026-02-27 |
| Moran Kyle | officer: Chief Financial Officer | 2026-02-05 | A-Award | 12.75 | 2026-02-11 |
| Moran Kyle | officer: Chief Financial Officer | 2026-02-05 | A-Award | 0 | 2026-02-11 |
| Moran Kyle | officer: Chief Financial Officer | 2026-02-09 | S-Sale | 13.45 | 2026-02-11 |
| BOLNO PAUL | director, officer: President and CEO | 2026-02-05 | A-Award | 12.75 | 2026-02-11 |
| BOLNO PAUL | director, officer: President and CEO | 2026-02-05 | A-Award | 0 | 2026-02-11 |
| BOLNO PAUL | director, officer: President and CEO | 2026-02-09 | S-Sale | 13.45 | 2026-02-11 |
| Francis Chris | officer: See Remarks | 2026-02-05 | A-Award | 12.75 | 2026-02-11 |
| Francis Chris | officer: See Remarks | 2026-02-05 | A-Award | 0 | 2026-02-11 |
| Francis Chris | officer: See Remarks | 2026-02-09 | S-Sale | 13.45 | 2026-02-11 |
| Vargeese Chandra | officer: See Remarks | 2026-02-05 | A-Award | 0 | 2026-02-11 |
| Vargeese Chandra | officer: See Remarks | 2026-02-09 | S-Sale | 13.45 | 2026-02-11 |
| Vargeese Chandra | officer: See Remarks | 2026-02-05 | A-Award | 12.75 | 2026-02-11 |
| Francis Chris | officer: See Remarks | 2026-01-02 | M-Exempt | 3.14 | 2026-01-06 |
| Francis Chris | officer: See Remarks | 2026-01-02 | S-Sale | 15.92 | 2026-01-06 |
| Francis Chris | officer: See Remarks | 2026-01-02 | S-Sale | 16.7 | 2026-01-06 |
| Francis Chris | officer: See Remarks | 2026-01-02 | M-Exempt | 3.14 | 2026-01-06 |
| GSK plc | 10 percent owner | 2025-12-11 | P-Purchase | 19 | 2025-12-15 |
| Rawcliffe Adrian | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| Rawcliffe Adrian | director | 2025-12-08 | S-Sale | 15 | 2025-12-10 |
| Rawcliffe Adrian | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| Wagner Heidi L | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| Wagner Heidi L | director | 2025-12-08 | S-Sale | 14 | 2025-12-10 |
| Wagner Heidi L | director | 2025-12-08 | S-Sale | 13 | 2025-12-10 |
| Wagner Heidi L | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | M-Exempt | 4.585 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | M-Exempt | 3.5 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | M-Exempt | 4.585 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | S-Sale | 18.02 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | S-Sale | 12.75 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | S-Sale | 14.07 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | M-Exempt | 3.5 | 2025-12-10 |
| HENRY CHRISTIAN O | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 4.585 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 5.37 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | S-Sale | 12.75 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 3.5 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | S-Sale | 12.75 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | S-Sale | 12.75 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | S-Sale | 15 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | S-Sale | 12.75 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 3.5 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 5.37 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 5.97 | 2025-12-10 |
| Tan Aik Na | director | 2025-12-08 | M-Exempt | 4.585 | 2025-12-10 |
| Verdine Gregory L. | director | 2025-12-08 | S-Sale | 13.09 | 2025-12-10 |
| Verdine Gregory L. | director | 2025-12-08 | S-Sale | 14.05 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.87 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 4.75 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.87 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 4.75 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 10.48 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 4.75 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.14 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.14 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 2.83 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.87 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.14 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | S-Sale | 14.556 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | S-Sale | 14.195 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | S-Sale | 15 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | S-Sale | 16 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | S-Sale | 14.5 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | S-Sale | 14.08 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 3.14 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 10.48 | 2025-12-10 |
| Francis Chris | officer: See Remarks | 2025-12-08 | M-Exempt | 2.83 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | A-Award | 4.75 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | M-Exempt | 3.14 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | M-Exempt | 2.83 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-09 | M-Exempt | 10.48 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | M-Exempt | 4.75 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | S-Sale | 15 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-09 | M-Exempt | 8.17 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-09 | S-Sale | 20.025 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-09 | S-Sale | 20.25 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | S-Sale | 13.2 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | S-Sale | 18 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-08 | A-Award | 3.14 | 2025-12-10 |
| Moran Kyle | officer: Chief Financial Officer | 2025-12-09 | A-Award | 10.48 | 2025-12-10 |